Ressources

Interventions visant à augmenter l’adoption du vaccin contre la COVID‐19: une revue exploratoire

Product: — Cochrane Library

Community Prevention & Transmission Public Health & Implementation Transmission Vaccine Vaccines & Immunity

www.cochranelibrary.com Dernière mise à jour: août 3, 2022

Also available in English

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: juin 6, 2022

Conséquences involontaires des mesures mises en œuvre dans le cadre scolaire pour contenir la pandémie de la COVID‐19: une revue exploratoire

Product: — Cochrane Library

Mental Health & Well-being Mental Wellness Regulation & Policy School Protocols Vulnerable Groups Vulnerable Sub-populations

www.cochranelibrary.com Dernière mise à jour: juin 6, 2022

Also available in English

Signes et symptômes permettant de déterminer si un patient se présentant dans un contexte de soins primaires ou en consultation externe à l’hôpital est atteint de la COVID‐19

Product: — Cochrane Library

Hospital Care Infectious Diseases & Clinical Care Most Common Signs & Symptoms Signs & Symptoms

www.cochranelibrary.com Dernière mise à jour: mai 20, 2022

Also available in English

The COVID‑19 Pandemic’s Impact on Long-Term Care Homes: Five Lessons Learned

Product: — Science Table

Community Prevention & Transmission Long-term & Community Care Long-term Care Public Prevention Transmission

covid19-sciencetable.ca Dernière mise à jour: avril 28, 2022

Therapeutic Management of Residents of Long-term Care Homes with COVID-19

Product: — Science Table

Infectious Diseases & Clinical Care Long-term & Community Care Long-term Care Treatments Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: avril 22, 2022

Increased Screen Time for Children and Youth During the COVID‑19 Pandemic

Product: — Science Table

Communications & Media Mental Health & Well-being Mental Wellness Physical Wellness Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: avril 12, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: avril 1, 2022

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022